A non-canonical role of the p97 complex in RIG-I antiviral signaling

EMBO Journal

Volumn 34, Issue 23, 2015, Pages 2903-2920

  Hao, Qian ^a   Jiao, Shi ^a   Shi, Zhubing ^a   Li, Chuanchuan ^a   Meng, Xia ^a   Zhang, Zhen ^a   Wang, Yanyan ^a   Song, Xiaomin ^a   Wang, Wenjia ^a   Zhang, Rongguang ^a   Zhao, Yun ^a   Wong, Catherine C L ^a   Zhou, Zhaocai ^a,b  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAITECH UNIVERSITY   (China)

Author keywords

antiviral signaling; mechanism; p97 Npl4; RIG I; ubiquitination

Indexed keywords

ANTIVIRUS AGENT; PROTEIN P97; RETINOIC ACID INDUCIBLE PROTEIN I; ADENOSINE TRIPHOSPHATASE; NUCLEAR PROTEIN; P97 ATPASE; PROTEASOME; PROTEIN BINDING; RARRES3 PROTEIN, HUMAN; RETINOIC ACID RECEPTOR; RNF125 PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE;

ANIMAL EXPERIMENT; ANTIVIRAL THERAPY; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; INNATE IMMUNITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; UBIQUITINATION; VESICULOVIRUS; VIRUS INFECTION; VIRUS REPLICATION; ANIMAL; CELL LINE; GENETICS; HELA CELL LINE; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VESICULAR STOMATITIS;

ADENOSINE TRIPHOSPHATASES; ANIMALS; CELL LINE; HELA CELLS; HUMANS; MICE; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN BINDING; RECEPTORS, RETINOIC ACID; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION; VESICULAR STOMATITIS; VIRUS REPLICATION;

EID: 84956572894     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.15252/embj.201591888     Document Type: Article

References (100)

1. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH, (2010) PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D Biol Crystallogr 66: 213-221
2. Alam SL, Sun J, Payne M, Welch BD, Blake BK, Davis DR, Meyer HH, Emr SD, Sundquist WI, (2004) Ubiquitin interactions of NZF zinc fingers. EMBO J 23: 1411-1421
3. Alexandru G, Graumann J, Smith GT, Kolawa NJ, Fang R, Deshaies RJ, (2008) UBXD7 binds multiple ubiquitin ligases and implicates p97 in HIF1alpha turnover. Cell 134: 804-816
4. Arimoto K, Takahashi H, Hishiki T, Konishi H, Fujita T, Shimotohno K, (2007) Negative regulation of the RIG-I signaling by the ubiquitin ligase RNF125. Proc Natl Acad Sci USA 104: 7500-7505
5. Asai T, Tomita Y, Nakatsuka S, Hoshida Y, Myoui A, Yoshikawa H, Aozasa K, (2002) VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res 93: 296-304
6. Ballar P, Shen Y, Yang H, Fang S, (2006) The role of a novel p97/valosin-containing protein-interacting motif of gp78 in endoplasmic reticulum-associated degradation. J Biol Chem 281: 35359-35368
7. Barbalat R, Ewald SE, Mouchess ML, Barton GM, (2011) Nucleic acid recognition by the innate immune system. Annu Rev Immunol 29: 185-214
8. Cao K, Nakajima R, Meyer HH, Zheng Y, (2003) The AAA-ATPase Cdc48/p97 regulates spindle disassembly at the end of mitosis. Cell 115: 355-367
9. Chan NC, den Besten W, Sweredoski MJ, Hess S, Deshaies RJ, Chan DC, (2014) Degradation of the deubiquitinating enzyme USP33 is mediated by p97 and the ubiquitin ligase HERC2. J Biol Chem 289: 19789-19798
10. Chen W, Han C, Xie B, Hu X, Yu Q, Shi L, Wang Q, Li D, Wang J, Zheng P, Liu Y, Cao X, (2013) Induction of Siglec-G by RNA viruses inhibits the innate immune response by promoting RIG-I degradation. Cell 152: 467-478
11. Chou TF, Brown SJ, Minond D, Nordin BE, Li K, Jones AC, Chase P, Porubsky PR, Stoltz BM, Schoenen FJ, Patricelli MP, Hodder P, Rosen H, Deshaies RJ, (2011) Reversible inhibitor of p97, DBeQ, impairs both ubiquitin-dependent and autophagic protein clearance pathways. Proc Natl Acad Sci USA 108: 4834-4839
12. Chou TF, Deshaies RJ, (2011) Development of p97 AAA ATPase inhibitors. Autophagy 7: 1091-1092
13. Dai RM, Chen E, Longo DL, Gorbea CM, Li CC, (1998) Involvement of valosin-containing protein, an ATPase Co-purified with IkappaBalpha and 26 S proteasome, in ubiquitin-proteasome-mediated degradation of IkappaBalpha. J Biol Chem 273: 3562-3573
14. Dreveny I, Kondo H, Uchiyama K, Shaw A, Zhang X, Freemont PS, (2004) Structural basis of the interaction between the AAA ATPase p97/VCP and its adaptor protein p47. EMBO J 23: 1030-1039
15. Emsley P, Lohkamp B, Scott WG, Cowtan K, (2010) Features and development of Coot. Acta Crystallogr D Biol Crystallogr 66: 486-501
16. Fan Y, Mao R, Yu Y, Liu S, Shi Z, Cheng J, Zhang H, An L, Zhao Y, Xu X, Chen Z, Kogiso M, Zhang D, Zhang P, Jung JU, Li X, Xu G, Yang J, (2014) USP21 negatively regulates antiviral response by acting as a RIG-I deubiquitinase. J Exp Med 211: 313-328
17. Feng M, Ding Z, Xu L, Kong L, Wang W, Jiao S, Shi Z, Greene MI, Cong Y, Zhou Z, (2013) Structural and biochemical studies of RIG-I antiviral signaling. Protein Cell 4: 142-154
18. Friedman CS, O'Donnell MA, Legarda-Addison D, Ng A, Cardenas WB, Yount JS, Moran TM, Basler CF, Komuro A, Horvath CM, Xavier R, Ting AT, (2008) The tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral response. EMBO Rep 9: 930-936
19. Fu X, Ng C, Feng D, Liang C, (2003) Cdc48p is required for the cell cycle commitment point at Start via degradation of the G1-CDK inhibitor Far1p. J Cell Biol 163: 21-26
20. Gack MU, Shin YC, Joo CH, Urano T, Liang C, Sun L, Takeuchi O, Akira S, Chen Z, Inoue S, Jung JU, (2007) TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446: 916-920
21. Gack MU, Nistal-Villan E, Inn KS, Garcia-Sastre A, Jung JU, (2010) Phosphorylation-mediated negative regulation of RIG-I antiviral activity. J Virol 84: 3220-3229
22. Gao D, Yang YK, Wang RP, Zhou X, Diao FC, Li MD, Zhai ZH, Jiang ZF, Chen DY, (2009) REUL is a novel E3 ubiquitin ligase and stimulator of retinoic-acid-inducible gene-I. PLoS ONE 4: e5760
23. Hanzelmann P, Buchberger A, Schindelin H, (2011) Hierarchical binding of cofactors to the AAA ATPase p97. Structure 19: 833-843
24. Hanzelmann P, Schindelin H, (2011) The structural and functional basis of the p97/valosin-containing protein (VCP)-interacting motif (VIM): mutually exclusive binding of cofactors to the N-terminal domain of p97. J Biol Chem 286: 38679-38690
25. Hauler F, Mallery DL, McEwan WA, Bidgood SR, James LC, (2012) AAA ATPase p97/VCP is essential for TRIM21-mediated virus neutralization. Proc Natl Acad Sci USA 109: 19733-19738
26. Heo JM, Livnat-Levanon N, Taylor EB, Jones KT, Dephoure N, Ring J, Xie J, Brodsky JL, Madeo F, Gygi SP, Ashrafi K, Glickman MH, Rutter J, (2010) A stress-responsive system for mitochondrial protein degradation. Mol Cell 40: 465-480
27. Hetzer M, Meyer HH, Walther TC, Bilbao-Cortes D, Warren G, Mattaj IW, (2001) Distinct AAA-ATPase p97 complexes function in discrete steps of nuclear assembly. Nat Cell Biol 3: 1086-1091
28. Higashiyama H, Hirose F, Yamaguchi M, Inoue YH, Fujikake N, Matsukage A, Kakizuka A, (2002) Identification of ter94, Drosophila VCP, as a modulator of polyglutamine-induced neurodegeneration. Cell Death Differ 9: 264-273
29. Huyton T, Pye VE, Briggs LC, Flynn TC, Beuron F, Kondo H, Ma J, Zhang X, Freemont PS, (2003) The crystal structure of murine p97/VCP at 3.6A. J Struct Biol 144: 337-348
30. Indig FE, Partridge JJ, von Kobbe C, Aladjem MI, Latterich M, Bohr VA, (2004) Werner syndrome protein directly binds to the AAA ATPase p97/VCP in an ATP-dependent fashion. J Struct Biol 146: 251-259
31. Isaacson RL, Pye VE, Simpson P, Meyer HH, Zhang X, Freemont PS, Matthews S, (2007) Detailed structural insights into the p97-Npl4-Ufd1 interface. J Biol Chem 282: 21361-21369
32. Jarosch E, Taxis C, Volkwein C, Bordallo J, Finley D, Wolf DH, Sommer T, (2002) Protein dislocation from the ER requires polyubiquitination and the AAA-ATPase Cdc48. Nat Cell Biol 4: 134-139
33. Jiang F, Ramanathan A, Miller MT, Tang GQ, Gale M Jr, Patel SS, Marcotrigiano J, (2011) Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479: 423-427
34. Ju JS, Fuentealba RA, Miller SE, Jackson E, Piwnica-Worms D, Baloh RH, Weihl CC, (2009) Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187: 875-888
35. Kato H, Takahasi K, Fujita T, (2011) RIG-I-like receptors: cytoplasmic sensors for non-self RNA. Immunol Rev 243: 91-98
36. Kawai T, Takahashi K, Sato S, Coban C, Kumar H, Kato H, Ishii KJ, Takeuchi O, Akira S, (2005) IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction. Nat Immunol 6: 981-988
37. Kawai T, Akira S, (2008) Toll-like receptor and RIG-I-like receptor signaling. Ann N Y Acad Sci 1143: 1-20
38. Kawai T, Akira S, (2010) The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol 11: 373-384
39. Kim NC, Tresse E, Kolaitis RM, Molliex A, Thomas RE, Alami NH, Wang B, Joshi A, Smith RB, Ritson GP, Winborn BJ, Moore J, Lee JY, Yao TP, Pallanck L, Kundu M, Taylor JP, (2013) VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 78: 65-80
40. Kobayashi T, Manno A, Kakizuka A, (2007) Involvement of valosin-containing protein (VCP)/p97 in the formation and clearance of abnormal protein aggregates. Genes Cells 12: 889-901
41. Kolakofsky D, Kowalinski E, Cusack S, (2012) A structure-based model of RIG-I activation. RNA 18: 2118-2127
42. Kondo H, Rabouille C, Newman R, Levine TP, Pappin D, Freemont P, Warren G, (1997) p47 is a cofactor for p97-mediated membrane fusion. Nature 388: 75-78
43. Konno H, Yamamoto T, Yamazaki K, Gohda J, Akiyama T, Semba K, Goto H, Kato A, Yujiri T, Imai T, Kawaguchi Y, Su B, Takeuchi O, Akira S, Tsunetsugu-Yokota Y, Inoue J, (2009) TRAF6 establishes innate immune responses by activating NF-kappaB and IRF7 upon sensing cytosolic viral RNA and DNA. PLoS ONE 4: e5674
44. Kowalinski E, Lunardi T, McCarthy AA, Louber J, Brunel J, Grigorov B, Gerlier D, Cusack S, (2011) Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147: 423-435
45. Krick R, Bremer S, Welter E, Schlotterhose P, Muehe Y, Eskelinen EL, Thumm M, (2010) Cdc48/p97 and Shp1/p47 regulate autophagosome biogenesis in concert with ubiquitin-like Atg8. J Cell Biol 190: 965-973
46. Lass A, McConnell E, Fleck K, Palamarchuk A, Wojcik C, (2008) Analysis of Npl4 deletion mutants in mammalian cells unravels new Ufd1-interacting motifs and suggests a regulatory role of Npl4 in ERAD. Exp Cell Res 314: 2715-2723
47. Latterich M, Frohlich KU, Schekman R, (1995) Membrane fusion and the cell cycle: Cdc48p participates in the fusion of ER membranes. Cell 82: 885-893
48. Li JM, Wu H, Zhang W, Blackburn MR, Jin J, (2014) The p97-UFD1L-NPL4 protein complex mediates cytokine-induced IkappaBalpha proteolysis. Mol Cell Biol 34: 335-347
49. Liu S, Chen ZJ, (2011) Expanding role of ubiquitination in NF-kappaB signaling. Cell Res 21: 6-21
50. Liu Y, Hei Y, Shu Q, Dong J, Gao Y, Fu H, Zheng X, Yang G, (2012) VCP/p97, down-regulated by microRNA-129-5p, could regulate the progression of hepatocellular carcinoma. PLoS ONE 7: e35800
51. Luo D, Ding SC, Vela A, Kohlway A, Lindenbach BD, Pyle AM, (2011) Structural insights into RNA recognition by RIG-I. Cell 147: 409-422
52. Maelfait J, Beyaert R, (2012) Emerging role of ubiquitination in antiviral RIG-I signaling. Microbiol Mol Biol Rev 76: 33-45
53. Magnaghi P, D'Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, Gasparri F, Cozzi L, Cucchi U, Orrenius C, Polucci P, Ballinari D, Perrera C, Leone A, Cervi G, Casale E, Xiao Y, Wong C, Anderson DJ, Galvani A, et al, (2013) Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat Chem Biol 9: 548-556
54. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ, (2007) Phaser crystallographic software. J Appl Crystallogr 40: 658-674
55. Meerang M, Ritz D, Paliwal S, Garajova Z, Bosshard M, Mailand N, Janscak P, Hubscher U, Meyer H, Ramadan K, (2011) The ubiquitin-selective segregase VCP/p97 orchestrates the response to DNA double-strand breaks. Nat Cell Biol 13: 1376-1382
56. Meyer H, Bug M, Bremer S, (2012) Emerging functions of the VCP/p97 AAA-ATPase in the ubiquitin system. Nat Cell Biol 14: 117-123
57. Meylan E, Curran J, Hofmann K, Moradpour D, Binder M, Bartenschlager R, Tschopp J, (2005) Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus. Nature 437: 1167-1172
58. Mouysset J, Deichsel A, Moser S, Hoege C, Hyman AA, Gartner A, Hoppe T, (2008) Cell cycle progression requires the CDC-48UFD-1/NPL-4 complex for efficient DNA replication. Proc Natl Acad Sci USA 105: 12879-12884
59. Nakhaei P, Genin P, Civas A, Hiscott J, (2009) RIG-I-like receptors: sensing and responding to RNA virus infection. Semin Immunol 21: 215-222
60. Nishikori S, Yamanaka K, Sakurai T, Esaki M, Ogura T, (2008) p97 Homologs from Caenorhabditis elegans, CDC-48.1 and CDC-48.2, suppress the aggregate formation of huntingtin exon1 containing expanded polyQ repeat. Genes Cells 13: 827-838
61. Oganesyan G, Saha SK, Guo B, He JQ, Shahangian A, Zarnegar B, Perry A, Cheng G, (2006) Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response. Nature 439: 208-211
62. O'Neill LA, Bowie AG, (2010) Sensing and signaling in antiviral innate immunity. Curr Biol 20: R328-R333
63. Onoguchi K, Yoneyama M, Fujita T, (2011) Retinoic acid-inducible gene-I-like receptors. J Interferon Cytokine Res 31: 27-31
64. Oshiumi H, Matsumoto M, Hatakeyama S, Seya T, (2009) Riplet/RNF135, a RING finger protein, ubiquitinates RIG-I to promote interferon-beta induction during the early phase of viral infection. J Biol Chem 284: 807-817
65. Oshiumi H, Matsumoto M, Seya T, (2012) Ubiquitin-mediated modulation of the cytoplasmic viral RNA sensor RIG-I. J Biochem 151: 5-11
66. Partridge JJ, Lopreiato JO Jr, Latterich M, Indig FE, (2003) DNA damage modulates nucleolar interaction of the Werner protein with the AAA ATPase p97/VCP. Mol Biol Cell 14: 4221-4229
67. Paz S, Vilasco M, Werden SJ, Arguello M, Joseph-Pillai D, Zhao T, Nguyen TL, Sun Q, Meurs EF, Lin R, Hiscott J, (2011) A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response. Cell Res 21: 895-910
68. Rabinovich E, Kerem A, Frohlich KU, Diamant N, Bar-Nun S, (2002) AAA-ATPase p97/Cdc48p, a cytosolic chaperone required for endoplasmic reticulum-associated protein degradation. Mol Cell Biol 22: 626-634
69. Ramadan K, Bruderer R, Spiga FM, Popp O, Baur T, Gotta M, Meyer HH, (2007) Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 450: 1258-1262
70. Raman M, Havens CG, Walter JC, Harper JW, (2011) A genome-wide screen identifies p97 as an essential regulator of DNA damage-dependent CDT1 destruction. Mol Cell 44: 72-84
71. Saha SK, Pietras EM, He JQ, Kang JR, Liu SY, Oganesyan G, Shahangian A, Zarnegar B, Shiba TL, Wang Y, Cheng G, (2006) Regulation of antiviral responses by a direct and specific interaction between TRAF3 and Cardif. EMBO J 25: 3257-3263
72. Sasagawa Y, Otani M, Higashitani N, Higashitani A, Sato K, Ogura T, Yamanaka K, (2009) Caenorhabditis elegans p97 controls germline-specific sex determination by controlling the TRA-1 level in a CUL-2-dependent manner. J Cell Sci 122: 3663-3672
73. Satoh T, Kato H, Kumagai Y, Yoneyama M, Sato S, Matsushita K, Tsujimura T, Fujita T, Akira S, Takeuchi O, (2010) LGP2 is a positive regulator of RIG-I- and MDA5-mediated antiviral responses. Proc Natl Acad Sci USA 107: 1512-1517
74. Seth RB, Sun L, Ea CK, Chen ZJ, (2005) Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. Cell 122: 669-682
75. Song EJ, Yim SH, Kim E, Kim NS, Lee KJ, (2005) Human Fas-associated factor 1, interacting with ubiquitinated proteins and valosin-containing protein, is involved in the ubiquitin-proteasome pathway. Mol Cell Biol 25: 2511-2524
76. Song C, Wang Q, Li CC, (2007) Characterization of the aggregation-prevention activity of p97/valosin-containing protein. Biochemistry 46: 14889-14898
77. Takeuchi O, Akira S, (2010) Pattern recognition receptors and inflammation. Cell 140: 805-820
78. Tanaka A, Cleland MM, Xu S, Narendra DP, Suen DF, Karbowski M, Youle RJ, (2010) Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 191: 1367-1380
79. Tresse E, Salomons FA, Vesa J, Bott LC, Kimonis V, Yao TP, Dantuma NP, Taylor JP, (2010) VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6: 217-227
80. Tsujimoto Y, Tomita Y, Hoshida Y, Kono T, Oka T, Yamamoto S, Nonomura N, Okuyama A, Aozasa K, (2004) Elevated expression of valosin-containing protein (p97) is associated with poor prognosis of prostate cancer. Clin Cancer Res 10: 3007-3012
81. Valle CW, Min T, Bodas M, Mazur S, Begum S, Tang D, Vij N, (2011) Critical role of VCP/p97 in the pathogenesis and progression of non-small cell lung carcinoma. PLoS ONE 6: e29073
82. Vesa J, Su H, Watts GD, Krause S, Walter MC, Martin B, Smith C, Wallace DC, Kimonis VE, (2009) Valosin containing protein associated inclusion body myopathy: abnormal vacuolization, autophagy and cell fusion in myoblasts. Neuromuscul Disord 19: 766-772
83. Wang Q, Shinkre BA, Lee JG, Weniger MA, Liu Y, Chen W, Wiestner A, Trenkle WC, Ye Y, (2010) The ERAD inhibitor Eeyarestatin I is a bifunctional compound with a membrane-binding domain and a p97/VCP inhibitory group. PLoS ONE 5: e15479
84. Wang Y, Tong X, Ye X, (2012) Ndfip1 negatively regulates RIG-I-dependent immune signaling by enhancing E3 ligase Smurf1-mediated MAVS degradation. J Immunol 189: 5304-5313
85. Xu LG, Wang YY, Han KJ, Li LY, Zhai Z, Shu HB, (2005) VISA is an adapter protein required for virus-triggered IFN-beta signaling. Mol Cell 19: 727-740
86. Xu S, Peng G, Wang Y, Fang S, Karbowski M, (2011) The AAA-ATPase p97 is essential for outer mitochondrial membrane protein turnover. Mol Biol Cell 22: 291-300
87. Yamamoto S, Tomita Y, Hoshida Y, Takiguchi S, Fujiwara Y, Yasuda T, Yano M, Nakamori S, Sakon M, Monden M, Aozasa K, (2003a) Expression level of valosin-containing protein is strongly associated with progression and prognosis of gastric carcinoma. J Clin Oncol 21: 2537-2544
88. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Nagano H, Dono K, Umeshita K, Sakon M, Monden M, Aozasa K, (2003b) Elevated expression of valosin-containing protein (p97) in hepatocellular carcinoma is correlated with increased incidence of tumor recurrence. J Clin Oncol 21: 447-452
89. Yamamoto S, Tomita Y, Hoshida Y, Iizuka N, Monden M, Yamamoto S, Iuchi K, Aozasa K, (2004a) Expression level of valosin-containing protein (p97) is correlated with progression and prognosis of non-small-cell lung carcinoma. Ann Surg Oncol 11: 697-704
90. Yamamoto S, Tomita Y, Nakamori S, Hoshida Y, Iizuka N, Okami J, Nagano H, Dono K, Umeshita K, Sakon M, Ishikawa O, Ohigashi H, Aozasa K, Monden M, (2004b) Valosin-containing protein (p97) and Ki-67 expression is a useful marker in detecting malignant behavior of pancreatic endocrine neoplasms. Oncology 66: 468-475
91. Yamamoto S, Tomita Y, Uruno T, Hoshida Y, Qiu Y, Iizuka N, Nakamichi I, Miyauchi A, Aozasa K, (2005) Increased expression of valosin-containing protein (p97) is correlated with disease recurrence in follicular thyroid cancer. Ann Surg Oncol 12: 925-934
92. Yamanaka K, Okubo Y, Suzaki T, Ogura T, (2004) Analysis of the two p97/VCP/Cdc48p proteins of Caenorhabditis elegans and their suppression of polyglutamine-induced protein aggregation. J Struct Biol 146: 242-250
93. Yamanaka K, Sasagawa Y, Ogura T, (2012) Recent advances in p97/VCP/Cdc48 cellular functions. Biochim Biophys Acta 1823: 130-137
94. Ye Y, Meyer HH, Rapoport TA, (2001) The AAA ATPase Cdc48/p97 and its partners transport proteins from the ER into the cytosol. Nature 414: 652-656
95. Ye Y, Meyer HH, Rapoport TA, (2003) Function of the p97-Ufd1-Npl4 complex in retrotranslocation from the ER to the cytosol: dual recognition of nonubiquitinated polypeptide segments and polyubiquitin chains. J Cell Biol 162: 71-84
96. Yoshida R, Takaesu G, Yoshida H, Okamoto F, Yoshioka T, Choi Y, Akira S, Kawai T, Yoshimura A, Kobayashi T, (2008) TRAF6 and MEKK1 play a pivotal role in the RIG-I-like helicase antiviral pathway. J Biol Chem 283: 36211-36220
97. You F, Sun H, Zhou X, Sun W, Liang S, Zhai Z, Jiang Z, (2009) PCBP2 mediates degradation of the adaptor MAVS via the HECT ubiquitin ligase AIP4. Nat Immunol 10: 1300-1308
98. Zeng W, Sun L, Jiang X, Chen X, Hou F, Adhikari A, Xu M, Chen ZJ, (2010) Reconstitution of the RIG-I pathway reveals a signaling role of unanchored polyubiquitin chains in innate immunity. Cell 141: 315-330
99. Zhang M, Wu X, Lee AJ, Jin W, Chang M, Wright A, Imaizumi T, Sun SC, (2008) Regulation of IkappaB kinase-related kinases and antiviral responses by tumor suppressor CYLD. J Biol Chem 283: 18621-18626
100. Zhang Z, Lv X, Yin WC, Zhang X, Feng J, Wu W, Hui CC, Zhang L, Zhao Y, (2013) Ter94 ATPase complex targets k11-linked ubiquitinated ci to proteasomes for partial degradation. Dev Cell 25: 636-644